Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Barton

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Science (New York, N.Y.)|March 17, 2018
Pleistocene North African genomes link Near Eastern and sub-Saharan African human populationsMarieke van de Loosdrecht, Abdeljalil Bouzouggar, Louise Humphrey, et al.
Drug Discovery Today|September 21, 2013
A practical drug discovery project at the undergraduate levelM Jonathan Fray, Simon J F Macdonald, Ian R Baldwin, et al.
Genetics|February 17, 2026
Beyond Mendel: a call to revisit the genotype-phenotype map through new experimental paradigmsDiethard Tautz, Luisa F Pallares, Leif Andersson, et al.
Journal of Medicinal Chemistry|December 20, 2019
Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity TargetZoë A Henley, Augustin Amour, Nick Barton, et al.
Journal of Medicinal Chemistry|September 13, 2021
Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding ModeKenneth Down, Augustin Amour, Niall A Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012
Volcanic ash layers illuminate the resilience of Neanderthals and early modern humans to natural hazardsJohn Lowe, Nick Barton, Simon Blockley, et al.
Journal of Medicinal Chemistry|October 25, 2019
Free-Wilson Analysis of Comprehensive Data on Phosphoinositide-3-kinase (PI3K) Inhibitors Reveals Importance of <i>N</i>-Methylation for PI3Kδ ActivityLydia Barnes, Hollie Blaber, David T K Brooks, et al.
Nature|March 25, 2011
Inclusive fitness theory and eusocialityPatrick Abbot, Jun Abe, John Alcock, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Science (New York, N.Y.)|March 17, 2018
Pleistocene North African genomes link Near Eastern and sub-Saharan African human populationsMarieke van de Loosdrecht, Abdeljalil Bouzouggar, Louise Humphrey, et al.
Drug Discovery Today|September 21, 2013
A practical drug discovery project at the undergraduate levelM Jonathan Fray, Simon J F Macdonald, Ian R Baldwin, et al.
Genetics|February 17, 2026
Beyond Mendel: a call to revisit the genotype-phenotype map through new experimental paradigmsDiethard Tautz, Luisa F Pallares, Leif Andersson, et al.
Journal of Medicinal Chemistry|December 20, 2019
Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity TargetZoë A Henley, Augustin Amour, Nick Barton, et al.
Journal of Medicinal Chemistry|September 13, 2021
Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding ModeKenneth Down, Augustin Amour, Niall A Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012
Volcanic ash layers illuminate the resilience of Neanderthals and early modern humans to natural hazardsJohn Lowe, Nick Barton, Simon Blockley, et al.
Journal of Medicinal Chemistry|October 25, 2019
Free-Wilson Analysis of Comprehensive Data on Phosphoinositide-3-kinase (PI3K) Inhibitors Reveals Importance of <i>N</i>-Methylation for PI3Kδ ActivityLydia Barnes, Hollie Blaber, David T K Brooks, et al.
Nature|March 25, 2011
Inclusive fitness theory and eusocialityPatrick Abbot, Jun Abe, John Alcock, et al.
Pageof 5